OPL Stock Overview
Engages in the development of digital tools that enhance healthcare experience for patients in Australia.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Opyl Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.017 |
52 Week High | AU$0.042 |
52 Week Low | AU$0.017 |
Beta | 1.89 |
11 Month Change | -15.00% |
3 Month Change | -29.17% |
1 Year Change | n/a |
33 Year Change | -89.70% |
5 Year Change | -83.00% |
Change since IPO | -99.63% |
Recent News & Updates
Recent updates
Shareholder Returns
OPL | AU Software | AU Market | |
---|---|---|---|
7D | 0% | 2.7% | 1.7% |
1Y | n/a | 68.0% | 17.2% |
Return vs Industry: Insufficient data to determine how OPL performed against the Australian Software industry.
Return vs Market: Insufficient data to determine how OPL performed against the Australian Market.
Price Volatility
OPL volatility | |
---|---|
OPL Average Weekly Movement | n/a |
Software Industry Average Movement | 8.4% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.4% |
10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: OPL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine OPL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | n/a | Saurabh Jain | www.opyl.ai |
Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations.
Opyl Limited Fundamentals Summary
OPL fundamental statistics | |
---|---|
Market cap | AU$2.90m |
Earnings (TTM) | -AU$3.13m |
Revenue (TTM) | AU$397.64k |
7.7x
P/S Ratio-1.0x
P/E RatioIs OPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OPL income statement (TTM) | |
---|---|
Revenue | AU$397.64k |
Cost of Revenue | AU$1.80m |
Gross Profit | -AU$1.40m |
Other Expenses | AU$1.73m |
Earnings | -AU$3.13m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.018 |
Gross Margin | -351.77% |
Net Profit Margin | -787.24% |
Debt/Equity Ratio | 0% |
How did OPL perform over the long term?
See historical performance and comparison